For the second year in a row, the average basic premium for a Medicare Part D plan will decline; a series of charts in The Wall Street Journal highlights what is driving US healthcare spending; taking a break from exercising can have metabolic consequences that linger for some people even after they return to their normal levels of exercise.
For the second year in a row, the average basic premium for a Medicare Part D plan will decline. According to CMS, Part D premiums are expected to fall from $33.59 in 2018 to $32.50 in 2019. In order to increase competition and drive down costs, CMS has introduced some changes, such as allowing for certain generic drugs to be substituted onto formularies more quickly and removing the requirement that certain Part D plans have to meaningfully differ from each other, which has made more plan options available and increased competition.
Healthcare costs in the United States are higher than other developed nations, but the cost isn’t high because Americans buy more healthcare. A series of charts in The Wall Street Journal highlighted what is driving US healthcare spending. Part of the issue is the opacity of the industry—patients don’t pay directly for services, instead the majority of health spending goes to paying for health insurance. The article highlighted the fact that consolidation also contributes to the overall increase in health costs.
Taking a break from exercising can have metabolic consequences that linger for some people even after they return to their normal levels of exercise, according to 2 new studies. The New York Times reported that the studies found that when volunteers reduced their daily step count and sat for more hours over the course of 2 weeks, their blood sugar levels rose and insulin resistance climbed. In addition, volunteers who started healthy began to lose muscle mass. Among volunteers who were older and already overweight, some had to be removed from the study because they “edged into full-blown type 2 diabetes.”
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
2 Commerce Drive
Cranbury, NJ 08512